Literature DB >> 15486126

Lack of association between baseline plasma homocysteine concentrations and restenosis rates after a first elective percutaneous coronary intervention without stenting.

C-K Wong1, C J K Hammett, R The, J K French, W Gao, B J Webber, J M Elliott, A W Hamer, J A Ormiston, M W I Webster, R A H Stewart, R V Ameratunga, H D White.   

Abstract

OBJECTIVE: To evaluate the association between baseline homocysteine concentrations and restenosis rates in patients electively undergoing their first percutaneous coronary intervention (PCI) without stenting.
DESIGN: Prospective, single centre, observational study. SETTING AND PATIENTS: Patients electively undergoing their first PCI without stenting at a tertiary referral centre between 1990 and 1998.
METHODS: Blood samples were collected from all patients at baseline and assayed to determine the patients' homocysteine concentrations. Patients whose PCI was successful underwent repeat angiography at a median of 6.4 (interquartile range 6-6.8) months. Their baseline and follow up angiograms were compared by quantitative coronary angiography to assess the incidence of restenosis. For the analysis, the patients were divided into two groups based on whether their baseline homocysteine concentrations were above or below the median value. These two groups were compared to determine whether there was any association between their baseline homocysteine concentrations and the incidence of restenosis at six months.
RESULTS: 134 patients had a successful first PCI without stenting (involving 200 lesions). At six month angiography, restenosis was observed in 33 patients (49.3%) with baseline homocysteine concentrations above the median value and in 31 patients (46.3%) with concentrations below the median value (p = 0.74). There was no difference in the percentage of lesions developing restenosis (38 (39.6%) v 40 (38.5%), respectively, p = 0.87) or late lumen loss (0.40 mm v 0.31 mm, respectively, p = 0.24). On multivariable analysis, there was no association between homocysteine concentrations and late lumen loss (r = -0.11, p = 0.11) or the percentage diameter stenosis at follow up (r = -0.07, p = 0.32).
CONCLUSION: Baseline homocysteine concentrations were not associated with six month restenosis rates in patients electively undergoing their first PCI without stenting.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15486126      PMCID: PMC1768545          DOI: 10.1136/hrt.2003.020701

Source DB:  PubMed          Journal:  Heart        ISSN: 1355-6037            Impact factor:   5.994


  19 in total

1.  Fish and long-chain omega-3 fatty acids could be lifesavers for diabetic women.

Authors:  Ruth SoRelle
Journal:  Circulation       Date:  2003-04-22       Impact factor: 29.690

2.  Plasma homocysteine levels and mortality in patients with coronary artery disease.

Authors:  O Nygård; J E Nordrehaug; H Refsum; P M Ueland; M Farstad; S E Vollset
Journal:  N Engl J Med       Date:  1997-07-24       Impact factor: 91.245

3.  Long-term follow-up of patients with mild coronary artery disease and endothelial dysfunction.

Authors:  J A Suwaidi; S Hamasaki; S T Higano; R A Nishimura; D R Holmes; A Lerman
Journal:  Circulation       Date:  2000-03-07       Impact factor: 29.690

4.  Can dietary supplements with folic acid or vitamin B6 reduce cardiovascular risk? Design of clinical trials to test the homocysteine hypothesis of vascular disease.

Authors:  R Clarke; R Collins
Journal:  J Cardiovasc Risk       Date:  1998-08

5.  Homocysteine and risk of ischemic heart disease and stroke: a meta-analysis.

Authors: 
Journal:  JAMA       Date:  2002 Oct 23-30       Impact factor: 56.272

6.  Clinical and quantitative coronary angiographic predictors of coronary restenosis: a comparative analysis from the balloon-to-stent era.

Authors:  N Mercado; E Boersma; W Wijns; B J Gersh; C A Morillo; V de Valk; G A van Es; D E Grobbee; P W Serruys
Journal:  J Am Coll Cardiol       Date:  2001-09       Impact factor: 24.094

7.  Homocysteine, lipoprotein(a), and restenosis after percutaneous transluminal coronary angioplasty: a prospective study.

Authors:  S E Miner; R A Hegele; J Sparkes; J M Teitel; K A Bowman; P W Connelly; H Banijamali; H K Lau; R J Chisholm; S Babaei; B H Strauss
Journal:  Am Heart J       Date:  2000-08       Impact factor: 4.749

8.  Thrombolysis in Myocardial Infarction (TIMI) Trial, Phase I: A comparison between intravenous tissue plasminogen activator and intravenous streptokinase. Clinical findings through hospital discharge.

Authors:  J H Chesebro; G Knatterud; R Roberts; J Borer; L S Cohen; J Dalen; H T Dodge; C K Francis; D Hillis; P Ludbrook
Journal:  Circulation       Date:  1987-07       Impact factor: 29.690

9.  Association of plasma homocysteine with restenosis after percutaneous coronary angioplasty.

Authors:  G Schnyder; M Roffi; Y Flammer; R Pin; O M Hess
Journal:  Eur Heart J       Date:  2002-05       Impact factor: 29.983

10.  Effect of homocysteine-lowering therapy with folic acid, vitamin B12, and vitamin B6 on clinical outcome after percutaneous coronary intervention: the Swiss Heart study: a randomized controlled trial.

Authors:  Guido Schnyder; Marco Roffi; Yvonne Flammer; Riccardo Pin; Otto Martin Hess
Journal:  JAMA       Date:  2002-08-28       Impact factor: 56.272

View more
  3 in total

1.  Serum Homocysteine Level Predictive Capability for Severity of Restenosis Post Percutaneous Coronary Intervention.

Authors:  Jiqiang Guo; Ying Gao; Mohammad Ahmed; Pengfei Dong; Yuping Gao; Zhihua Gong; Jinwen Liu; Yajie Mao; Zhijie Yue; Qingli Zheng; Jiansheng Li; Jianrong Rong; Yongnian Zhou; Meiwen An; Linxia Gu; Jin Zhang
Journal:  Front Pharmacol       Date:  2022-05-24       Impact factor: 5.988

2.  Hyperhomocysteinemia accelerates collagen accumulation in the adventitia of balloon-injured rat carotid arteries via angiotensin II type 1 receptor.

Authors:  Dan Yao; Ning-Ling Sun
Journal:  Int J Mol Sci       Date:  2014-10-27       Impact factor: 5.923

3.  Homocysteine is associated with the progression of non-culprit coronary lesions in elderly acute coronary syndrome patients after percutaneous coronary intervention.

Authors:  Tian-Wen Han; Shan-Shan Zhou; Jian-Tao Li; Feng Tian; Yang Mu; Jing Jing; Yun-Feng Han; Yun-Dai Chen
Journal:  J Geriatr Cardiol       Date:  2016-05       Impact factor: 3.327

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.